Education Library

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS) during high risk intervention, highlighting the following topics...

Babar Basir, D.O., discusses revascularization best practices in patients with cardiogenic shock.

In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.

This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.

Javier Escaned, MD, opens the session titled “How to optimize high-risk patient outcome?” at EuroPCR 2023.

Vasileios Panoulas, MD, discusses data regarding completeness of revascularization in high-risk PCI with mechanical circulatory support (MCS) at EuroPCR 2023.

Javier Escaned, MD, Nikos Werner, MD, Dirk Westermann, MD, and Vasileios Panoulas, MD, answer questions following the EuroPCR session “How to optimize high-risk patient outcome?”

“The precarious balance between bleeding and thrombosis in patients with p-LVAD support is often the primary reason that patients’ outcomes are jeopardized,” write the authors of this article, which discusses anticoagulation strategies and anticoagulant management in the setting of Protected PCI.

This article describes pre-procedural preparation, with a particular focus on imaging techniques for screening and guiding vascular access in patients undergoing Protected PCI.

Four physicians from the heart team at Tampa General Hospital discuss their approach to high-risk revascularization in patients with heart failure.

Fadi Al-Rashid, MD, discusses his publication on standard pre-procedural clinical workup for Protected PCI.

Prof. Dr. Jan-Malte Sinning discusses optimal revascularization strategies during protected high-risk procedures with Impella® heart pumps.

William O’Neill, MD, and Alejandro Lemor, MD, compare insurance databases to the cVAD registry and discuss factors that characterize high-risk patients requiring MCS.

Alejandro F. Lemor, MD, disusses A-SMART-EF, a new risk score for predicting outcomes in patients supported with Impella® during PCI.

William O’Neill, MD, defines high-risk PCI and explains how to decide when to use mechanical circulatory support in this short interview.